Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles
- PMID: 18200053
- DOI: 10.1038/sj.jid.5701243
Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles
Abstract
Basal-cell carcinoma (BCC), the most common neoplasm in humans, occurs in a variety of morphological presentations. The mechanisms of BCC development downstream of the initial genetic mutations are not well understood, and different BCC morphological presentations might exhibit distinct gene expression patterns. We investigated superficial (n=8), nodular (n=8), and morpheiform (n=7) BCCs using 21K cDNA microarrays. Global gene expression profiles between respective BCC subtypes, and as compared with normal skin (n=8), were statistically defined by significance analysis of microarrays (SAM). Thirty-seven genes were subsequently validated by quantitative reverse transcriptase-PCR analysis using an expanded set of 31 BCCs. Gene ontology analysis indicated that gene expression patterns of BCC subtypes in multiple biological processes showed significant variation, particularly in genes associated with the mitogen-activated protein kinase (MAPK) pathway. Notably, genes involved in response to DNA-damage stimulus were uniquely upregulated in morpheiform BCCs. Our results indicate a relative similarity in gene expression between nodular and superficial BCC subtypes. In contrast, morpheiform BCCs are more diverse, with gene expression patterns consistent with their more "invasive" phenotype. These data may help us understand the complex behavior of BCC subtypes and may eventually lead to new therapeutic strategies.
Similar articles
-
Altered Expression of PRKX, WNT3 and WNT16 in Human Nodular Basal Cell Carcinoma.Anticancer Res. 2016 Sep;36(9):4545-51. doi: 10.21873/anticanres.11002. Anticancer Res. 2016. PMID: 27630294
-
Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.Mol Med Rep. 2017 Apr;15(4):1441-1454. doi: 10.3892/mmr.2017.6163. Epub 2017 Feb 2. Mol Med Rep. 2017. PMID: 28259916 Free PMC article.
-
Molecular classification of basal cell carcinoma of skin by gene expression profiling.Mol Carcinog. 2015 Dec;54(12):1605-12. doi: 10.1002/mc.22233. Epub 2014 Oct 18. Mol Carcinog. 2015. PMID: 25328065
-
Basal cell carcinoma: a dermatopathological and molecular biological update.Br J Dermatol. 2003 Feb;148(2):195-202. doi: 10.1046/j.1365-2133.2003.05151.x. Br J Dermatol. 2003. PMID: 12588368 Review.
-
Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.Semin Oncol. 2012 Apr;39(2):139-44. doi: 10.1053/j.seminoncol.2012.01.011. Semin Oncol. 2012. PMID: 22484185 Review.
Cited by
-
Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth.PLoS One. 2012;7(5):e34185. doi: 10.1371/journal.pone.0034185. Epub 2012 May 16. PLoS One. 2012. PMID: 22615732 Free PMC article.
-
[Non-melanoma skin cancer : Pathogenesis, prevalence and prevention].Hautarzt. 2017 Nov;68(11):919-928. doi: 10.1007/s00105-017-4058-5. Hautarzt. 2017. PMID: 29018888 Review. German.
-
Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi.Thyroid. 2021 Jul;31(7):1114-1126. doi: 10.1089/thy.2020.0391. Epub 2021 Mar 13. Thyroid. 2021. PMID: 33509032 Free PMC article.
-
CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas.Am J Pathol. 2010 May;176(5):2435-46. doi: 10.2353/ajpath.2010.081059. Epub 2010 Mar 12. Am J Pathol. 2010. PMID: 20228225 Free PMC article.
-
Molecular Profiling and the Interaction of Somatic Mutations with Transcriptomic Profiles in Non-Melanoma Skin Cancer (NMSC) in a Population Exposed to Arsenic.Cells. 2024 Jun 18;13(12):1056. doi: 10.3390/cells13121056. Cells. 2024. PMID: 38920684 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials